US FDA classifies recall of Abiomed's blood pumps as most serious

Reuters03-21

March 21 (Reuters) - The U.S. health regulator on Thursday classified the recall of some Impella Left Sided Blood Pumps by Abiomed, a Johnson & Johnson company, as the most serious and said that its use could cause serious injuries or death.

(Reporting by Bhanvi Satija in Bengaluru; Editing by Anil D'Silva)

((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91 9873062788;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment